Physician profile
Ava Schmidt
NPI 1962903427
$2,073.92
in general payments reported to CMS, 2019-2025
15 companies · $51.94 in 2025
The $51.94 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $272 · 2022: $455 · 2023: $902 · 2024: $392 · 2025: $51.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,346.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $607.50 | 2021-2025 | Xifaxan, Trulance |
| Abbvie INC. | $600.69 | 2022-2024 | |
| Daiichi Sankyo INC. | $252.69 | 2021-2024 | Injectafer |
| Lilly USA, LLC | $184.08 | 2021-2024 | Jardiance, Emgality, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.20 | 2021-2024 | Jardiance |
| Novo Nordisk INC | $58.90 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $54.05 | 2022-2025 | Farxiga |
| Exact Sciences Corporation | $39.69 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $39.36 | 2021-2022 | |
| Pfizer INC. | $32.06 | 2021 | |
| Nestle Healthcare Nutrition INC. | $30.69 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.10 | 2022 | |
| Upsher-Smith Laboratories LLC | $18.35 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.38 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.18 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ava Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.